Iowa has chosen its sole low-potency medical marijuana manufacturer, a new Des Moines company led by owners of an Iowa food-ingredient maker.
MedPharm Iowa is expected to get the state’s only marijuana production license, according to the Des Moines Register.
The production license is the byproduct of an expansion of Iowa’s MMJ law earlier this year to cover more conditions.
Iowa’s 2017 “Medical Cannabidiol Act” is unusual.
The law defines MMJ as cannabis products up to 3% THC, which contains 10 times more THC than the 0.3% limit federal regulators imposed on hemp.
Some, but not all, cannabis users say they could feel intoxicated by marijuana containing 3% THC.
Iowa has yet to award licenses for five dispensaries permitted under the new CBD law.
MedPharm Iowa is led by Chris Nelson, president of Kemin Industries, a Des Moines-based company that makes ingredients for foods and supplements for humans and animals.
MedPharm Iowa is affiliated with MedPharm Colorado, which is managed by Andy Williams, CEO of Denver-based Medicine Man.
MedPharm Iowa says it plans to grow and process the marijuana indoors at Kemin’s campus.
The state also has yet to clarify which marijuana products will be allowed.
Iowa’s MMJ law bans “edible medical cannabidiol products,” but health authorities will decide later whether that means pills and tinctures are allowed.